VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2007 SESSION

• history | hilite | pdf | print version

072451396
HOUSE BILL NO. 2123 Offered January 10, 2007 Prefiled January 8, 2007 A BILL to amend and reenact § 54.1-2971.1 of the Code of Virginia, relating to disclosure of risks of gamete donations and identity of donors. ---------- Patron-- Marshall, R.G. ---------- Referred to Committee on Health, Welfare and Institutions ----------

Be it enacted by the General Assembly of Virginia:

1.  That § 54.1-2971.1 of the Code of Virginia is amended and reenacted as follows:

§ 54.1-2971.1. Disclosure for certain treatment of infertility; no anonymous donation.

A. Before a physician commences treatment of a patient by in vitro fertilization, gamete intrafallopian tube transfer, or zygote intrafallopian tube transfer, including the administration of drugs for the stimulation or suppression of ovulation prefatory thereto, a disclosure form shall have been executed by the patient which includes, but need not be limited to, the rates of success for the particular procedure at the clinic or hospital where the procedure is to be performed. The information disclosed to the patient shall include the testing protocol used to ensure that gamete donors are free from known infection with human immunodeficiency viruses, the total number of live births, the number of live births as a percentage of completed retrieval cycles, and the rates for clinical pregnancy and delivery per completed retrieval cycle bracketed by age groups consisting of women under thirty years of age, women aged thirty through thirty-four years, women aged thirty-five through thirty-nine years, and women aged forty years and older.

B. In addition, any woman donating ova for use by another person shall sign a disclosure detailing all known risks of such donation, including (i) risks associated with the administration of ovulation stimulation drugs and (ii) risks associated with the harvesting of the ova.

C. No anonymous donation of gametes shall be allowed for use in any procedure for the treatment of infertility pursuant to this section.